Literature DB >> 24118875

Increased levels of PD-1 expression on CD8 T cells in patients post-renal transplant irrespective of chronic high EBV viral load.

Julie Moran1, Jonathan Dean, Andre De Oliveira, Marie O'Connell, Michael Riordan, Jeff Connell, Atif Awan, William W Hall, Jaythoon Hassan.   

Abstract

Studies have identified solid organ transplant recipients who remain asymptomatic despite maintaining CHL. Factors which determine the CHL state remain poorly understood but are likely to involve immunological control of the viral infection. We monitored expression of PD-1, a marker of T-cell exhaustion and viral persistence, on CD8 T cells in patients who resolved EBV infection as determined by undetectable EBV DNA (REI) and CHL patients. PD-1 expression on CD8 T cells was increased in the first year post-transplant irrespective of EBV outcome, and most CD8 T cells continued to express PD-1 for up to three yr post-transplant. Although all patient groups showed similar frequencies of EBV-specific CD8+ T cells, PD-1 expression on these cells increased in the post-transplant groups compared with the pretransplant patients. Functional studies of EBV-specific CD8+ T cells stimulated with BZLF or LMP2 peptide pools revealed monofunctional IFN-γ responses. Our results indicate that PD-1 expression on CD8 T cells post-transplant may result from factors other than antigenic stimulation.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CD8+ T cell; EBV; cytokines

Mesh:

Substances:

Year:  2013        PMID: 24118875     DOI: 10.1111/petr.12156

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  5 in total

Review 1.  The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.

Authors:  Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2017-09       Impact factor: 4.939

2.  High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder.

Authors:  Hideaki Saito; Hiroaki Miyoshi; Hirohiko Shibayama; Jun Toda; Shinsuke Kusakabe; Michiko Ichii; Jiro Fujita; Kentaro Fukushima; Tetsuo Maeda; Masao Mizuki; Kenji Oritani; Masao Seto; Takafumi Yokota; Yuzuru Kanakura; Naoki Hosen; Koichi Ohshima
Journal:  Int J Hematol       Date:  2021-03-25       Impact factor: 2.490

3.  Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.

Authors:  Janice K P Lam; Tarik Azzi; K F Hui; Aikha M G Wong; Donal McHugh; Nicole Caduff; K H Chan; Christian Münz; Alan K S Chiang
Journal:  Front Immunol       Date:  2020-06-17       Impact factor: 7.561

4.  Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients.

Authors:  Cecilia Nakid-Cordero; Nadia Arzouk; Nicolas Gauthier; Nadine Tarantino; Martin Larsen; Sylvain Choquet; Sonia Burrel; Brigitte Autran; Vincent Vieillard; Amélie Guihot
Journal:  PLoS One       Date:  2019-10-22       Impact factor: 3.240

5.  [The diagnostic value of whole blood Epstein-Barr virus DNA load in lymphoproliferative diseases after allogeneic hematopoietic stem cell transplantation].

Authors:  Y Y Niu; Y J Dong; Y Yin; W L Xu; Z Y Liang; Q Wang; Y Li; W Liu; J P Ou; H Y Ren
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.